Form 4: Angiodynamics Executive Receives Stock Grant
Insider Transaction (Form 4)
Warren Nighan Jr, SVP Quality and Regulatory of Angiodynamics Inc, reported multiple transactions in common stock on July 15, 2026.
Summary
- Grant/award: acquired 17,966 Common Stock on July 15, 2026; holds 84,092 after (Direct).
- Grant/award: acquired 17,966 Performance Right on July 15, 2026; holds 17,966 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Warren Nighan Jr — Officer (SVP Quality and Regulatory)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-07-15 | Grant/award | Common Stock | 17,966 | — | — | 84,092 |
| 2026-07-15 | Grant/award | Performance Right | 17,966 | — | — | 17,966 |
Key Dates
| Date | Description |
|---|---|
| 2026-07-15 | Grant/award (17,966 shares) |
| 2026-07-15 | Grant/award (17,966 shares) |
Keywords
insider transaction, Form 4, ANGO, ANGIODYNAMICS INC, neutral, Warren Nighan Jr
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.